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Objective: Gold nanoparticles (GNPs) have the potential to enhance the effects of radiation therapy, using Auger electrons to cause additional damage to tumors. In this
work, we explore the effect of two clinically important variables: dose fractionation and radiation energy. In clinical radiation therapy, radiation is fractionated (split into multiple
sessions) and high-energy radiation is used. However, in the
field of GNP research, radiation has generally been given
in one session and lower radiation energies have generally
been used.
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Methods: Mice with JC breast tumors implanted in the
flank were given radiation therapy over 1, 2, or 4 fractions,
with radiation energies of either 250 kilovolts peak or 350
kilovolts peak. A survival analysis and a weighted generalized estimating equation analysis were used to.
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Results: The use of multiple radiation fractions (between 1 and 4) and the use of radiation doses between
250-350 kVp were only different by statistically insignificant
amounts, after the contributions from time, sex, age at irradiation and original tumor volume were accounted for. A
survival analysis found a higher likelihood of death for female mice, mice given 350 kilovolts peak radiation (versus
250 kilovolts peak), and mice with larger tumors, as well as
a lower likelihood of death for mice irradiated at an older
age; fractionated radiation did not have a statistically significant effect.
Conclusion: These results suggest that GNPs have the
potential to enhance radiation therapy when used with
fractionated radiation.
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Introduction

•

Gold nanoparticle preparation

Gold nanoparticles (GNPs) have been shown to have the potential to enhance radiation therapy [1-22]. Gold absorbs significantly better than human tissue [23], and after an interaction
with radiation gold releases extra electrons via the Auger effect.
Depending on the situation, there could be the potential for approximately 10 extra electrons per interaction, although some
electrons may interact inside of the nanoparticles themselves
[24].

Monomaleido 1.9 nm gold nanoparticles were purchased
from Nanoprobes, Inc. (stock number 2010). Gold nanoparticles were conjugated to pH-Low Insertion Peptide using the
same methodology as Sah et al [16].
Mouse experiment
Mouse experimental protocols were approved by the Institutional Animal Care and Use Committee (IACUC) at the University of Rhode Island. The 43 Balb/C mice tracked for tumor
size in this experiment were purchased from Envigo. At approximately 5-15 weeks of age, mice were injected in the right
flank (after hair removal with cream) with approximately 1.5
million JC (mouse breast cancer, from ATCC) cells in a 100 μL
mixture with Roswell Park Memorial Institute (RPMI) medium.
When mouse tumors reached approximately 5-8 mm in length
(similar to Yao et al. [29]), mice were injected intratumorally
with approximately 200 μg of GNPs (similar to Sah et al. [16]),
conjugated to pH-Low Insertion Peptide, in a 50 μL mixture with
phosphate buffer solution. Age of mice at irradiation is included
in supplementary table S1.

Although GNPs have been shown to have potential, gold has
not yet translated to clinical use. In this work, we examine the
effect in vivo of an important clinical variable: radiation dose
fractionation. In clinical radiation therapy, it is very common for
treatments to be done in fractions (multiple sessions), which allow healthy tissue time to heal during the treatments [25]. Yet,
of all of the animal experiments done with GNPs and radiation
therapy, to the authors’ knowledge only one experiment has
used fractionated radiation with GNPs, and this experiment did
not compare fractionated radiation treatments with a treatment
involving only one radiation treatment [19]. This may be because
GNPs can leave the body quickly – for example, in a pioneering
work Hainfeld et al. [9] gave (one fraction of) radiation therapy
only minutes after the injection of gold. In previous work in the
authors’ laboratory [16], we found that an appreciable amount
of gold stayed in mouse tumors for at least one week (after intratumoral injection) when conjugated to the cancer-targeting
molecule pH-Low Insertion Peptide [26]. This period of time is
fairly close to the total time period used for fractionated radiation therapy in human cancer in the CHART study (continuous
hyperfractionated accelerated radiation treatment), which gave
36 radiation fractions over 12 days [25,27].

Some mice were injected with tumors, but the tumors did
not grow; these mice were excluded from the rest of the experiment. The authors excluded age at injection from the statistical
analyses to avoid multicollinearity because age at injection was
strongly correlated with age at irradiation.
4 hours after injection (similar to Sah et al. [16]), mice were
irradiated in a cabinet x-ray machine (Faxitron MultiRad 350;
dose measured using an ionization chamber from Radcal). A
total dose of 20 gray of radiation was given to mice, over 1, 2
or 4 dose fractions. Mice given 2 dose fractions were given 10
gray per fraction on consecutive days; mice given 4 dose fractions were given 5 gray per fraction on each of 4 consecutive
days. Due to an issue with number of mice, no female mice
were given 4 radiation fractions. Mice were irradiated with lead
covering all but an approximate semi-circle of diameter 1 inch
around the tumor (dose similar to Sah et al. [16]); shape similar
to Hainfeld et al. [9]). Maximum voltage of the machine was
set to either 250 kiloVolts peak (250 kVp (keV peak) radiation
energy spectrum) or 350 kiloVolts (350 kVp). A Thoraeus-1 filter
was used on the radiation. Supplementary table S1 shows the
number of mice in each experimental group: 7 males and 7 females in 250 kVp/1fraction. 3 males and 6 females in 250 kVp/2
fractions, 6 males and 0 females in 250 kVp/4 fractions, 7 males
and 7 females in 350 kVp/1 fraction.

As a secondary result, we looked at the effect of radiation
energy. With the exception of the jumps at shell energies (Kshell, L-shell, M-shell for the photoelectric effect), the absorption of radiation by gold (mass attenuation coefficient) decreases with increasing photon energy until approximately 4 MeV,
then increases by roughly 50% by 20 MeV. In particular, the
mass attenuation coefficient decreases by a factor of approximately 105 between 100 keV (a representative imaging energy)
and 10 MeV (a representative treatment energy) (data from the
National Institute of Standards and Technology [28], inspired by
figure in Hainfeld et al. [23]). Despite this, several papers have
shown that GNPs can still be effective at MeV-scale radiation
energies (for example, [6,7,12,15,17] In this paper, we compare
two energies: 250 and 350 kVp (kilovolts peak).
The overall goal of this paper is to contribute to the ongoing investigation into the clinical relevance of GNPs. The results
shown below shed further light onto the effect of dose fractionation and radiation energy.

Mouse tumor size was tracked for approximately one month
after irradiation. Any data recorded in days 1-28 was included in
the analysis and plots (days 29-30 may not have been recorded,
for example, if days 29 and 30 were a weekend; some but not
all mice were recorded for a few days past 30). Mice were euthanized, using carbon dioxide, if mice reached the end time
point, if mice reached the maximum tumor size (20 mm, one
mouse), if mice had necrotic skin (one mouse) or if mice were
sick (one mouse, which was hunched). 14 of the 43 mice were
found dead. Supplementary table S1 shows each mouse, the
treatment it was given, and the reason for euthanasia (or if it
was found dead). Tumor volume was calculated using the formula volume = (1/2)*(length)*(width)2, where length is larger
than width [30].

Methods
Overall Outline of Work
The overall outline of the experimental work can be summarized as:
•

Inject mice with cells

•

Inject mice with gold nanoparticle treatment

•

Irradiate: over 1, 2 or 4 fractions (24 hours apart); radiation energy either 250 kVp or 350 kVp
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Measure tumor size as a function of time
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Mice were anesthetized using isoflurane gas anesthesia during 3 types of procedures: Hair removal/cell injection, nanoparticle injection and irradiation.

Cox regression analysis [33] was further performed to evaluate whether the occurrence of early death of mice was associated with certain covariates, including age of mouse at irradiation, tumor volume at irradiation, sex, radiation energy, and
radiation fractions. Hazard ratios and associated p values were
reported for each covariate.

Two mice were injected intravenously with GNPs, instead
of intratumorally (intentionally). Due to the small sample size,
these mice were not included in the plots or analysis.

Results

Analysis

WGEE- The model for longitudinal response

We considered the longitudinal tumor size measurements
of 45 mice between day 0 to day 28. Some mice were euthanized during the study when tumors reached a large size (approx. 20 mm length) or when skin became necrotic. The reasons of dropout were thus known (listed in supplementary table
S1) and were also included in the analysis as covariates, which
makes the missing data mechanism most likely missing at random (MAR). Thus, an observation-specific weighted generalized
estimating equation (WGEE) [31] was adopted to analyze the
tumor size data, where each measure was weighted by the inverse probability of being observed using a logistic regression
model. Furthermore, the identity link function was assumed,
and the compound symmetric working correlation structure
was selected using the deviance information criterion (DIC) [32]
based on the completely observed data. Covariates considered
in the WGEE approach include day number after irradiation,
age of mouse at irradiation, tumor volume at irradiation, sex
(male or female), radiation energy and radiation fractions. All
the continuous covariates were standardized. Comparisons of
treatment groups in terms of radiation fractions (1, 2, and 4)
were done, with corrections for multiple hypothesis testing using a Tukey-Kramer adjustment.

Results of the tumor size measurements are shown in figure
1, and the analysis of these measurements is shown in tables 1
and 2. The results of the analysis show that log (time), log(time)
squared, age at irradiation and tumor volume at irradiation
are statistically significant. The dependence on log(time) and
(log(time))2 suggests that the tumors have exponential behavior with time. Tumor volume at the time of irradiation is significant, indicating that a larger original tumor volume leads to
larger tumor volumes at later time points compared to tumors
that started at a smaller volume. An effect on tumor size from
age at irradiation may be related to the fact that radiation can
affect organisms of different ages in different ways – for examples, see Hall and Giaccia [25].
Table 1. Results of longitudinal analysis. The logarithm of
time, the square of logarithm of time, age at irradiation, tumor
volume at irradiation and sex are found to have a statistically
significant effect on tumor volume as a function of time. The
effect of energy was found to be statistically insignificant. The
number of radiation fractions is best evaluated by comparing all
of the values to each other, which is done in table 2.

Table 1: Results of longitudinal analysis.
Parameter Estimates for Response Model with Empirical Standard Error Estimates
Parameter

Estimate

Standard Error

95% Confidence
Limits

Z Score

P Value (Prob. > |Z|)

Intercept

-0.3579

0.1669

(-0.6850, -0.0307)

-2.14

0.0321

Log(time)

-0.5313

0.0797

(-0.6874,-0.3751)

-6.67

<0.0001

(Log(time))2

0.2201

0.0292

(0.1630,0.2773)

7.55

<0.0001

Age at Irradiation

-0.2378

0.0599

(-0.3552,-0.1204)

-3.97

<0.0001

Tumor Volume at
Irradiation

0.1506

0.0629

(0.0274,0.2738)

2.40

0.0166

Sex

Female, compared to Male

0.5093

0.1780

(0.1604,0.8581)

2.86

0.0042

Energy

350 kVp, compared to 250 kVp

-0.0291

0.1586

(-0.3401,0.2818)

-0.18

0.8543

Number of Radiation Fractions

2, compared to 1

0.5000

0.2413

(0.0270,0.9730)

2.07

0.0383

Number of Radiation Fractions

4, compared to 1

0.3350

0.1838

(-0.0252,0.6953)

1.82

0.0683

As shown in table 2, the different values for radiation fraction (1, 2, and 4 fractions) are not different from each other by
a statistically significant fraction. This result is interesting, because it takes place in a model where other statistically signifi-
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cant variables are accounted for. This suggests that GNPs can be
similarly effective with fractionated radiation, and at different
radiation energies.
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Table 2: Comparison of means for radiation fractionation. P values were adjusted for multiple hypothesis testing using the TukeyKramer method [34].
Differences of Least Squares Means
Treatment 1

Treatment 2

Estimate (Treatment
1 – Treatment 2)

Standard Error

z Value

P Value (Prob. > |z|)

Adjusted P Value

2 Radiation Fractions

4 Radiation Fractions

0.1649

0.2321

0.71

0.4774

0.7572

2 Radiation Fractions

1 Radiation Fraction

0.5000

0.2413

2.07

0.0383

0.0958

4 Radiation Fractions

1 Radiation Fraction

0.3350

0.1838

1.82

0.0683

0.1621

WGEE-The model for missingness

an older age and mice given two radiation fractions were less
likely to be missing (two radiation fractions compared to mice
given one radiation fraction). The added risk to female mice
may be because this experiment uses breast cancer. With the
radiation fractions, it’s possible that the use of two radiation
fractions allows healthy tissue more ability to recover (similar
to chapter 23 in [25]).

To reduce the bias caused by missing data (i.e. the mice no
longer being in the data set after being euthanized or found
dead), each longitudinal tumor size measure was weighted by
the inverse probability of being observed using a logistic regression model. The results of this analysis are shown in table 3.
Female mice were found to be more likely to be missing (represented by a negative estimate). In addition, mice irradiated at

Table 3: Missingness model (reasons for mice with missing data points). A negative value for estimate means more likely to be
missing. Results show that mice with larger tumor volumes and female mice were less likely to be seen in the model. Mice given 2 radiation
dose fractions were more likely to be seen than mice given only one radiation dose fraction.
Parameter Estimates for Missingness Model
Estimate

Standard Error

95% Confidence
Limits

Z Score

P Value (Prob. >
|Z|)

8.8814

3.5392

(1.9447,15.8181)

2.51

0.0121

-3.2227

2.9422

(-8.9893,2.5440)

-1.10

0.2734

0.4946

0.6093

(-0.6997,1.6888)

0.81

0.4170

yt-1

-0.2793

0.1347

(-0.5434,-0.0152)

-2.07

0.0382

Age at Irradiation

0.9680

0.4589

(0.0685,1.8674)

2.11

0.0349

Tumor Volume at
Irradiation

-0.1361

0.2433

(-0.6129,0.3407)

-0.56

0.5759

Female, compared to Male

-1.1771

0.5011

(-2.1592,-0.1950)

-2.35

0.0188

350 kVp, compared to 250 kVp

-0.0444

0.5298

(-1.0829,0.9940)

-0.08

0.9331

Number of Radiation
Fractions

2, compared to 1

2.6522

1.0515

(0.5913,4.7132)

2.52

0.0117

Number of Radiation
Fractions

4, compared to 1

0.9333

1.1167

(-1.2554,3.1221)

0.84

0.4033

Parameter
Intercept
Log(time)
(Log(time))

2

Sex
Energy

Survival model

higher risk of early deaths. The age of mice at irradiation was
found to have a reverse effect – younger mice (at time of irradiation) were associated with a significantly increased risk of
early deaths. The use of 2 or 4 radiation fractions resulted in a
statistically insignificant effect.

As mentioned in the methods section and supplementary
table S1, several mice were found dead at various points in the
experiment. To examine the effect of experimental variables on
this effect, a survival analysis was run. The results of this analysis, shown in table 4, found that mice with larger initial tumor
volumes, female mice, and mice given 350 kVp radiation had
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Table 4: Survival analysis results. Negative values for estimate mean that survival was more likely; positive values for estimate
mean that survival was less likely. Statistically significant variables with less likely survival included larger tumors (at time of irradiation), female mice and mice given 350 kVp radiation. Older mice (at time of irradiation) were more likely to survive. Chi-square is equal to (estimate/
standard error)2; hazard ratio = exp (estimate).
Parameter

Degrees of Freedom

Estimate

Standard Error

Chi-Square

P Value

Hazard Ratio

Age at Irradiation

1

-3.43806

0.82965

17.1728

<0.0001

0.032

Tumor Volume at
Irradiation

1

0.76861

0.31463

5.9679

0.0146

2.157

Female, vs. Male

1

2.70689

0.68295

15.7096

<0.0001

14.983

350 kVp, vs. 250 kVp

1

1.86470

0.62243

8.9751

0.0027

6.454

Radiation Fractions

2, vs. 1

1

-1.45585

0.84453

2.9717

0.0847

0.233

Radiation Fractions

4, vs. 1

1

-1.65536

1.70830

0.9390

0.3325

0.191

Sex
Energy

Conclusion
The longitudinal analysis of tumor size results described in
this paper (tables 1 and 2) indicate that 1, 2 and 4 fractions of
radiation were differently only by a statistically insignificant
amount after other covariates such as sex, tumor volume at irradiation and age at irradiation were accounted for. The missingness model (table 3) found that female mice were less likely
to survive, and mice were more likely to survive if irradiated
at an older age or given two radiation fractions (compared to
one radiation fraction). In a survival analysis (table 4), higher
radiation energy (350 kVp), female mice, mice with larger initial
tumors, and mice irradiated at an early age had higher risk of
early deaths.
Overall, these results suggest that GNPs could be useful in
fractionated radiation done over multiple days, since the tumor
size is not significantly changed and the missingness model indicates that the mice are actually somewhat more likely to survive. This is consistent as well with the gold uptake results in
Sah et al. [16]), which show that GNPs (targeted using pH-Low
Insertion Peptide) can be made to stay in a mouse for at least
one week.
With radiation energy, 250 and 350 kVp treatment energies produced similar tumor volumes, although 350 kVp resulted in reduced survival. Previous research suggests that
GNPs can be useful at higher radiation energies (for example,
[6,7,12,15,17]).

Figure 1: Tumor volume as a function of time after irradiation,
in female (A) and male (B) mice.
Mean and standard error of the mean are plotted; any
plot with no error bars is a data point from only one mouse. Analysis shows that the number of fractions and the radiation energy
have no statistically significant effect once other important variables such as initial tumor volume and age at irradiation are accounted for.

Since the one existing paper using fractionated radiation
and GNPs (Geng et al. [19]) did not compare fractionated radiation with non-fractionated radiation, a comparison between
the two papers’ results cannot be done. However, it is promising that Geng et al. found that fractionated radiation plus GNPs
(conjugated to polyethylene glycol and glucose) reduced tumor
size compared to fractionated radiation alone. The “250 kVp, 1
fraction” group in this experiment (figure 1) followed the same
methodology as the “Targeted Gold + Rad” treatment in previous work by our research group [16]. The mice in the previous
work saw tumor volume decrease by a factor of approximately
2-3 over one month; here, the tumor volumes increased by approximately 60-70% by the end of one month. In the female
mice, the average tumor size (a significant variable in table 1)
was larger in this experiment; in the male mice, the tumor volume was reduced at approximately 15 days but then increased,
perhaps suggesting an age-related effect; the age at injection
was significantly more varied overall in the previous work.

Future research could definitely improve on these results. It
would be useful to compare the results to a matching fractionated radiation treatment that does not use GNPs, and perhaps a
different size of GNP could be found to produce stronger reductions in tumor size. More fractions (and smaller doses per fraction) would be useful, as would testing a wider array of radiation energies, using intravenous injections and having female
mice for every fractionation level.
This research suggests that GNPs may be able to achieve clinical relevance. Hopefully future work will advance this position
further, and hopefully GNPs will someday be clinically useful.
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